Question 1: Core Updates in Risk Factors and Etiology

1. Quantified Risk Factors

• Hypertension, diabetes, and smoking are identified as independent risk factors
• Menopausal duration plays a critical role: women with >5 years of menopause have >3 times higher risk of developing uterine cavity effusion compared to those with <5 years

2. Revised Understanding of Hormone Therapy

3. Malignancy Risk Early Warning Matrix

• Endometrial thickness
• Effusion volume
• Blood flow signals (Doppler findings)
• Presence of vaginal bleedingThis integrated approach enables early identification of potentially malignant cases. 

Clinical Approach to Risk Stratification: "One Question, Two Examinations, Three Evaluations"

Step 1: "One Question" - Comprehensive History Taking

• Menopausal duration
• Chronic conditions (hypertension, diabetes)
• Smoking history
• Previous hormone therapy
• Relevant surgical history

Step 2: "Two Examinations" - Focused Clinical Assessment

1. Transvaginal ultrasound: precisely measure single-layer endometrial thickness and effusion volume (critical for risk stratification)
2. Visual inspection: assess for any abnormal discharge or bleeding

Step 3: "Three Evaluations" - Comprehensive Risk Assessment

Question 2: Management of Asymptomatic Patients with Risk Factors

Precise Baseline Assessment (First Step)

• Transvaginal ultrasound is the preferred initial modality
• Accurate measurement of endometrial thickness and effusion volume is essential for subsequent risk stratification
• Results serve as the foundation for treatment decisions

Risk Stratification Management (Core Implementation)

• Endometrial thickness <3mm AND effusion volume <5mm
• Management: 6-12 monthly follow-up with transvaginal ultrasound
• Disease control: optimize hypertension/diabetes management
• Lifestyle modification: smoking cessation, weight management 

• Endometrial thickness ≥3mm OR effusion volume ≥5mm
• Strong recommendation: hysteroscopy (gold standard for direct visualization and biopsy)
• Allows detection of subtle lesions missed by ultrasound
• Prevents potential missed diagnosis of endometrial malignancy

Dynamic Monitoring and Patient Education (Long-term Management)

• For patients on follow-up protocols: clear instructions on warning symptoms requiring immediate consultation
• Emphasize: any vaginal bleeding or discharge after menopause is abnormal and requires urgent evaluation
• Establish dual monitoring system: clinical follow-up + patient self-monitoring
• Promote patient awareness and empowerment as "first 责任人" for their health

Question 3: Individualized Treatment Approach

Diagnostic Algorithm

1. Initial screening: transvaginal ultrasound (TVUS)
2. Confirmatory diagnosis: hysteroscopy with biopsy (for high-risk cases)
3. Advanced evaluation: MRI (for complex cases or suspected malignancy)

Treatment Matching by Etiology

• Key indicators: lower abdominal pain, turbid fluid, echogenic particles in cavity
• Treatment: antimicrobial therapy based on culture results
• Surgery is not first-line treatment to avoid unnecessary trauma

• Features: recurrent effusion, difficult drainage, no infection/malignancy signs
• Treatment: cervical dilation + drainage tube placement to relieve obstruction
• Resolves recurrence by addressing the root cause

• Diagnosis: confirmed endometrial cancer by pathology
• Treatment: comprehensive cancer management (not just effusion control)
• Follow endometrial cancer treatment guidelines

• Profile: elderly, asymptomatic, slightly thickened endometrium (e.g., 3.5mm), comorbidities
• Approach: hysteroscopy first to rule out malignancy
• If normal: long-term management + close follow-up
• Control underlying conditions (e.g., hypertension)

Key Principles of Individualized Treatment

1. Root cause-oriented: address the underlying etiology rather than just symptoms
2. Risk-adaptive: match treatment intensity to risk level
3. Patient-centered: balance efficacy with quality of life
4. Dynamic decision-making: treatment plans evolve based on diagnostic findings

Summary

• From general to specific approaches
• From passive detection to active screening
• From symptom management to risk stratification

• Quantified risk factors (menopause >5 years triples risk)
• Reaffirmed protective role of proper hormone therapy
• Evidence-based risk stratification with "one question, two examinations, three evaluations"
• Stepwise diagnostic and treatment algorithms

Expert Profile

• Director, Department of Obstetrics and Gynecology
• Director, Gynecology Teaching and Research Office
• Director, Obstetrics and Gynecology Residency Training Base
• First Affiliated Hospital of Zhengzhou University
• National Health Commission Expert on Gynecological Endocrinology
• Member, Chinese Anti-Cancer Association Ovarian Cancer Committee
• President, Henan Medical Doctor Association Obstetrics and Gynecology Committee 

Editor-in-Charge: Lily